Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI. - Wikidata - awgldk - TriplyDB

Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.

Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.

http://www.wikidata.org/entity/Q37718443

about

Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis.Radiopharmaceutical tracers for cardiac imaging.Somatostatin receptor based hybrid imaging in sarcoidosis

P2860

Q37703212-94BEC698-8019-4D8C-89BD-9803A03DDCBE Q47258811-A3E85AD3-6ACE-4E4E-886F-51AC2BA37655 Q49352380-5563573E-958A-4518-A248-7F7C6FC19F4E Q56764232-09BCB504-9F27-45C4-BE7B-0DFA2F16E872

P2860

Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.

http://www.wikidata.org/entity/Q37718443

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Somatostatin receptor based PE ...... ial comparison to cardiac MRI.

@en

Somatostatin receptor based PE ...... ial comparison to cardiac MRI.

@nl

type

label

Somatostatin receptor based PE ...... ial comparison to cardiac MRI.

@en

Somatostatin receptor based PE ...... ial comparison to cardiac MRI.

@nl

prefLabel

Somatostatin receptor based PE ...... ial comparison to cardiac MRI.

@en

Somatostatin receptor based PE ...... ial comparison to cardiac MRI.

@nl

P1433

Q37718443-C70707BF-50D0-412C-9C27-E7A1F6C9B956

P1476

Q37718443-8334E1FE-A01D-4324-A1DC-8BE4272E5C08

P2093

Q37718443-0BB73DEF-2E1F-48C9-BE7F-49C21B1B373D

Q37718443-1CBEEF1E-A482-42A0-A019-DD33A2BE2D32

Q37718443-23DC3C04-E704-4E00-910E-B85AB3FB97A7

Q37718443-2473BB12-73B7-443D-85AE-1E5D58BFEF9A

Q37718443-2AD916FC-4D95-4A56-84E6-CC6C01F00244

Q37718443-30F554FF-3F3B-44B5-BB07-9013FA7E19D0

Q37718443-55979925-2A2C-4E14-B38D-E2BB8A8CC89B

Q37718443-696313D2-F822-4E8E-B1BC-247E762BF5FE

Q37718443-7F986D66-602B-4F07-899C-FF039655DBC8

Q37718443-9671AA4B-30EA-4ADD-9825-4494206FEF99

P2860

Q37718443-074F95BC-1964-4B5E-8958-41D01E3EB417

Q37718443-0D4D9B0D-E01C-4903-AA72-94DF209813E5

Q37718443-125FA422-C40E-4CB8-A495-B6F804402CEE

Q37718443-12F9FDBF-7775-4E7A-9678-D8C86DB514F6

Q37718443-25A9470E-7D1A-4D55-828A-DAE999C28C73

Q37718443-287C0581-6F95-497E-8A03-B6E81602CE15

Q37718443-34840825-D407-4373-AF1E-AD6521355AEA

Q37718443-37616A10-0651-4802-9A9A-67D5E1CEC07D

Q37718443-429A95D1-5CBF-4E9D-AC1A-6135296E41EA

Q37718443-522EA63D-EF6A-49E6-A69F-0068C0AB4D04

P304

Q37718443-C84750A1-5207-4E46-87D9-988B4492BA88

P31

Q37718443-1F140300-8918-4E1F-8F2D-7EE9EFB4F149

P356

Q37718443-73CAB90C-84BB-4FD8-999E-FD3311DAE520

P407

Q37718443-B4E93DD6-7234-4264-B4B4-519CAF3095A4

P433

Q37718443-9CC22324-09ED-4BAA-A570-B1DFF5F6037D

P478

Q37718443-3D358D7D-A1D4-44E6-9583-409A7A2F0E21

P577

Q37718443-B266D815-1E7E-4046-B39F-A3A4CBBCE4A0

P698

Q37718443-0B50C086-B20D-4F83-AF8A-5F28A50A03EC

P932

Q37718443-CA803FCD-17DB-4C03-BC43-9B987A601887

P356

ONCOTARGET.12799

P1433

P1476

Somatostatin receptor based PE ...... ial comparison to cardiac MRI.

@en

P2093

Andreas Schirbel

http://www.w3.org/2001/XMLSchema#string

Carmen Pizarro

http://www.w3.org/2001/XMLSchema#string

Constantin Lapa

http://www.w3.org/2001/XMLSchema#string

Daniel Thomas

http://www.w3.org/2001/XMLSchema#string

Dirk Skowasch

http://www.w3.org/2001/XMLSchema#string

Florian C Gärtner

http://www.w3.org/2001/XMLSchema#string

Lena Thomas

http://www.w3.org/2001/XMLSchema#string

Malte Kircher

http://www.w3.org/2001/XMLSchema#string

Ralph A Bundschuh

http://www.w3.org/2001/XMLSchema#string

Rudolf A Werner

http://www.w3.org/2001/XMLSchema#string

P2860

The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience

Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.

(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors.

Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data.

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Socie

A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis.

The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities.

Detection of myocardial damage in patients with sarcoidosis

P304

77807-77814

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.12799

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27780922

http://www.w3.org/2001/XMLSchema#string

P932

5363622

http://www.w3.org/2001/XMLSchema#string